Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on on healthcare or medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine. For up-to-date information on other healthcare topics, please consult the relevant reliable sources or an healthcare expert, such as a physician etc.
BACK TO LIST

European Patient Summary

Patient
Name: Beffa, Francesco
DOB: 16-JAN-1963 (Age: 63)
Gender: male
ID: 8775-026644-4 (ECI)
Author
Albertini, Clelia
Patient summary Document
European Patient Summary
Report Date: 29-MAY-2025

Problem list

Condition Onset Date / Period Status
Essential hypertension 29-May-2025 active
Metabolic syndrome X 29-May-2025 active
Ischemic heart disease 22-Feb-2018 active
Sepsis 24-Apr-2013 active
Anemia 21-May-1987 active
Acute infective cystitis 06-Sep-2024 - 07-Sep-2024 inactive
Sprain of ankle 27-May-2022 - 23-Jun-2022 inactive
Viral sinusitis 23-Feb-2018 - 05-Mar-2018 inactive
Laceration of foot 01-Jun-2016 - 19-Jun-2016 inactive
Laceration - injury 01-Jun-2016 - 19-Jun-2016 inactive

Medication list

Medication Since Form Dosage Reason
Hydrochlorothiazide 25 mg oral tablet 2025-06-28 - 1 tablet (25 mg) by mouth once daily Essential hypertension (disorder)
Lisinopril 10 mg oral tablet 2025-05-29 - 1 tablet (10 mg) by mouth once daily Essential hypertension (disorder)
Acetaminophen 300 mg and hydrocodone bitartrate 5 mg oral tablet 2025-05-29 - 1 tablet (300 mg/5 mg) by mouth every 4 to 6 hours as needed for pain -
Clopidogrel (as clopidogrel bisulfate) 75 mg oral tablet 2018-03-01 - 1 tablet (75 mg) once daily -
Simvastatin 20 mg oral tablet 2018-03-01 - 1 tablet (20 mg) by mouth once daily -
Nitroglycerin 400 microgram/actuation sublingual spray 2018-03-01 - 400 micrograms (1 spray) under the tongue as needed for chest pain, may repeat every 5 minutes as needed, up to 3 sprays in 15 minutes -
Metoprolol tartrate (as metoprolol succinate) 100 mg prolonged-release oral tablet 2018-03-01 - 1 tablet (100 mg) once daily -

Immunizations list

Vaccine Date
Influenza virus antigen only vaccine product 29-May-2025
Clostridium tetani toxoid antigen adsorbed only vaccine product 18-May-2023
SARS-CoV-2 mRNA vaccine 08-Apr-2021

Procedure History list

Procedure Date Reason
Suture open wound 01-Jun-2016 Laceration of foot (disorder)

Allergies and Intolerances

Allergy/Intolerance Onset Date Status Type Reaction
House dust mite 1963-02-10 active environment
Allergy to drug 1963-02-10 active environment
Shellfish 1963-02-10 active food Eruption of skin (disorder)<br> </br>Allergic angioedema (disorder)
Tree pollen 1963-02-10 active environment

Care Plan

Active Planned Care / Goals Start Date Reason
Lifestyle education regarding hypertension 29-May-2025 Essential hypertension (disorder)
  • Maintain blood pressure below 130/80 mmHg through lifestyle modifications.
Diabetes self management plan 03-Oct-1985 Prediabetes (finding)
  • Patient will verbalize understanding of prediabetes, including diet, exercise, and blood glucose monitoring strategies.
  • Patient will achieve and maintain HbA1c below 5.7% to reduce risk of progression to diabetes.
  • Patient will achieve a 5% reduction in body weight through dietary changes and increased physical activity.
  • Patient will achieve fasting plasma glucose below 100 mg/dL.
  • Patient will engage in at least 150 minutes of moderate-intensity physical activity per week.
Self-care interventions 26-Jan-1963 -
Immunization Recommendation Due Date Reason
Influenza virus antigen only vaccine product 01-Oct-2026 Annual seasonal influenza vaccination

Vital Signs

Vital Signs 2025-06-28 2025-05-29
Blood pressure panel with all children optional 86 mm[Hg] 96 mm[Hg]
Body Height - 168 cm
Pain severity - 0-10 verbal numeric rating [Score] - Reported - 2 {score}
Body Weight - 78.3 kg
Body mass index (BMI) [Ratio] - 27.8 kg/m2
Heart rate - 98 /min
Respiratory rate - 14 /min

Relevant diagnostic tests/laboratory data

Recent Lab Observations 29-MAY-2025 Reference Range Unit
Hemoglobin A1c/Hemoglobin.total in Blood 5.8 4.8 - 5.9 %
Glucose [Mass/volume] in Blood 99.5 70 - 100 mg/dL
Urea nitrogen [Mass/volume] in Blood 7.5 7 - 20 mg/dL
Creatinine [Mass/volume] in Blood 0.8 0.7 - 1.3 mg/dL
Calcium [Mass/volume] in Blood 9.1 8.5 - 10.5 mg/dL
Sodium [Moles/volume] in Blood 143.3 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 4.5 3.5 - 5.1 mmol/L
Chloride [Moles/volume] in Blood 103.1 98 - 107 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 21.2 L 22 - 29 mmol/L

Device Use

Device Date (since)
Blood glucose meter (physical object) 03-Oct-1985